Riskpilot← Back to searchSign inGet full accessCODAN NORGE AS
ASActiveOrg 938940258Ask, 2022 GjerdrumWholesale of pharmaceutical and medical goods · NACE 4646Est. 198610 employees
Revenue 2024
NOK 107,4M
+2% vs 2023
EBITDA margin
11.4%
+144% vs 2023
Equity ratio
54.4%
Financial strength
Net profit 2024
NOK 8,5M
+219% vs 2023
| Revenue | NOK 107,4M | +2% |
| EBITDA | NOK 12,2M | +144% |
| Net profit | NOK 8,5M | +219% |
| Total assets | NOK 53,7M | +20% |
| Equity | NOK 29,2M | -5% |
| Employees | 10 | — |
Legal name
CODAN NORGE AS
Org number
938940258
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12. mai 1986
Share capital
—
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder og ett styremedlem i fellesskap.
Address
Ask, 2022 Gjerdrum
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 75 724 | 80 833 | 81 013 | 105 734 | 107 397 |
| Staff expenses | −7 841 | −8 267 | −9 440 | −10 358 | −10 567 |
| EBITDA | 4 417 | 8 002 | 5 646 | 5 002 | 12 190 |
| Depreciation & amort. | −299 | −239 | −239 | −1 510 | −1 539 |
| EBIT | 4 118 | 7 763 | 5 407 | 3 492 | 10 651 |
| Net financials | −245 | 68 | 664 | −67 | 284 |
| Profit before tax | 3 873 | 7 830 | 6 070 | 3 426 | 10 936 |
| Tax | 852 | 1 725 | 1 336 | 755 | 2 409 |
| Net profit | 3 021 | 6 106 | 4 734 | 2 670 | 8 527 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 33 698 | 43 144 | 41 659 | 44 925 | 53 732 |
| Equity | 26 180 | 28 286 | 31 020 | 30 691 | 29 217 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 518 | 14 858 | 10 639 | 14 234 | 24 514 |
| Total debt | 7 518 | 14 858 | 10 639 | 14 234 | 24 514 |
EBITDA margin
11.4%
This company
15.8%
Market median
-28% vs market
20202024
Equity ratio
54.4%
This company
38.2%
Market median
+42% vs market
20202024
Return on equity
29.2%
This company
18.4%
Market median
+59% vs market
20202024
Net profit margin
7.9%
This company
8.1%
Market median
-2% vs market
20202024
Asset turnover
2.00×
This company
1.12×
Market median
+79% vs market
20202024
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SR Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
SR Chief Executive Officer | Chief Executive Officer | 2009 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Codan Holding Ag | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CODAN NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Svenn Roger Tufteland | Chief Executive Officer | 0 companies |
| Svend Reiten | Chief Executive Officer | 0 companies |
| Deirdre Husted-Andersen | Chairman | 0 companies |
| Stefanie Husted-Andersen | Board of Directors | 0 companies |
| Alexandra Husted-Andersen | Board of Directors | 0 companies |